» Authors » Maiiada H Nazmy

Maiiada H Nazmy

Explore the profile of Maiiada H Nazmy including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 168
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Fawzy M, Nazmy M, El-Sheikh A, Fathy M
Immunol Res . 2024 Jan; 72(3):438-449. PMID: 38240953
Recombination-activating gene 1 (RAG1) is a vital player in V(D)J recombination, a fundamental process in primary B cell and T cell receptor diversification of the adaptive immune system. Current vertebrate...
2.
Nazmy M, Abu-Baih D, Elrehany M, Mustafa M, Aly O, El-Sheikh A, et al.
Front Biosci (Landmark Ed) . 2023 Sep; 28(8):185. PMID: 37664933
Background: Breast cancer is the most predominant tumor in women. Even though current medications for distinct breast cancer subtypes are available, the non-specificity of chemotherapeutics and chemoresistance imposes major obstacles...
3.
Eltahir H, Elbadawy H, Alalawi A, Aldhafiri A, Ibrahim S, Mohamed G, et al.
Acta Biochim Pol . 2023 Apr; 70(2):277-284. PMID: 37068203
Alpha mangostin (AM), isolated from G. mangostana, showed beneficial effects in several disorders due to its antioxidant and anti-inflammatory properties. Acute kidney injury (AKI) due to different etiologies can develop...
4.
Fathi A, Waz S, Alaaeldin E, Toni N, El-Sheikh A, Sayed A, et al.
Metabolites . 2023 Mar; 13(3). PMID: 36984859
Aims: To achieve site-specific delivery of blackberry leaves extract () loaded AgNPs to the hepatocyte in IRI and to verify possible molecular mechanisms. Methods: IRI was induced in male Wister...
5.
Fawzy M, Abu-Baih R, Abuo-Rahma G, Abdel-Rahman I, El-Sheikh A, Nazmy M
Molecules . 2023 Feb; 28(3). PMID: 36770806
Novel drugs are desperately needed in order to combat a significant challenge due to chemo-therapeutic resistance and bad prognosis. This research aimed to assess the anticancer activity of a newly...
6.
Tharwat E, Gad G, Nazmy M, Mohamed H, Hamza N, Wahid A, et al.
Immunol Invest . 2018 Sep; 48(3):255-267. PMID: 30204505
Background: Hepatitis C virus (HCV) is a universal health problem. HCV infection may proceed to liver fibrosis, cirrhosis, and eventually hepatocellular carcinoma (HCC). The latest is the third leading global...
7.
Eltahir H, Nazmy M
Biomed Pharmacother . 2017 Nov; 97:1356-1365. PMID: 29156525
Background: Hepatic fibrosis is a major health problem that requires further medical attention. Proton pump inhibitors are proven to possess other therapeutic potentials apart of their acid anti-secretory actions. Aim...
8.
Fawzy M, Wahid A, Nazmy M, Hashem M, Waked I, Abdelwahab S
Asian Pac J Cancer Prev . 2016 May; 17(4):2093-7. PMID: 27221901
Background: HCV is a major global health problem. IL-27 is a member of the IL-6/IL-12 cytokine family with a broad range of anti-inflammatory properties. Recent studies highlighted the effect of...
9.
Abd El-Rehim D, Abd-Elghany M, Nazmy M
J Egypt Natl Canc Inst . 2015 May; 27(3):129-37. PMID: 25964055
Background: Integrin Linked Kinase (ILK), Snail and Multidrug Resistance Protein 1 (MRP1) have been implicated in several cancers; however, their roles in non-small cell lung cancer (NSCLC) remain to be...
10.
Abdel-Hamid N, Nazmy M, Abdel-Ghany M, Nazmy W
Ann Hepatol . 2011 Dec; 11(1):118-27. PMID: 22166570
Purpose: To explore the possible intermediary pathways through which diabetes mellitus (DM) adversely worsens hepatocellular carcinoma (HCC), focusing on cell life controllers as some transcription factors and inflammatory mediators. Material...